Introduction
Physical inactivity and obesity represent two of the greatest threats to public health in Canada. The most recent estimates indicate that 53.5% of Canadian adults are physically inactive while 14.7% are obese (Statistics Canada, 2002) . Given that both physical inactivity and obesity are strong independent predictors of illness and disability (U.S. Dept. of Health and Human Services [HHS] , 1996; U.S. National Institutes of Health [NIH] , 1998), it has been estimated that they impose a significant burden on the health care system in Canada (Birmingham et al., 1999; Katzmarzyk et al., 2000) .
Birmingham and colleagues have reported that obesity accounted for $1.8 billion, or 2.4% of the total direct health care expenditures in Canada in 1997 (Birmingham et al., 1999) . Although that study provided the direct health costs of obesity (e.g., drugs, hospital and physician care), the indirect health care costs such as work loss due to disability were not reported. Thus the total impact of obesity on the Canadian economy is unknown. Similarly, an estimate of the economic burden attributed to physical inactivity has also been reported for Canada (Katzmarzyk et al., 2000) . In 1999, physical inactivity accounted for $2.1 billion, or 2.5% of the total direct health care expenditures in Canada. Again, the estimations were also limited to direct health care costs alone, so the total impact (direct + indirect costs) of physical inactivity on the Canadian economy is unknown.
The primary objective of this analytical review is to summarize the evidence linking physical inactivity and obesity to chronic diseases and to provide estimates of the direct, indirect, and total health care expenditures that are attributable to physical inactivity and obesity in Canada. Further, the most recent definitions (cutoffs) and tracking data for physical inactivity and obesity from the 2000/2001 Canadian Community Health Survey were used to provide the most up-to-date estimates of the economic impact of these risk factors.
Methods
The economic costs of physical inactivity and obesity in Canada were estimated using a prevalence-based approach. First the relationships between physical inactivity, obesity, and associated chronic diseases were quantified at the population level. To accomplish this, the specific diseases associated with physical inactivity and obesity were determined from secondary reviews of original research (Bouchard et al., 1994; U.S. NIH, 1998 ; U.S. Dept. HHS, 1996) , and from more recent research communications identified by computerized searches of MEDLINE. Comprehensive lists of prospective longitudinal studies assessing the relationship between both physical inactivity and obesity and their respective associated conditions were developed based on the results of the literature search (Tables 1 and 2 ). Coronary Artery Disease Finnish women (Salonen et al., 1982) 3,688 none vs some leisure 1.50 (0.82-2.76)* Finnish men (Salonen et al., 1982) 3,978 none vs some leisure 1.20 (0.85-1.56)* Swedish women (Lapidus and Bengtsson, 1986) 1,424 leisure group I (low) vs groups (II-IV) 2.80 (1.20-6.50)
MRFIT men (Leon et al., 1987) 12,138 low vs middle tertile 1.56 (1.14-2.13)
Asian-American men (45-64 y) (Donahue et al., 1988) 7,644 active vs inactive 1.45 (1.14-1.89)
Finnish women and men (Salonen et al., 1988) 15,088 low vs high leisure-time activity 1.30 (1.10-1.60)
British civil servants (45-54 y) (Morris et al., 1990) 9,376 frequent/intense activity vs none 2.70 (1.30-5.56)
British men (Shaper and Wannamethee, 1991) 5,714 low vs moderate physical activity 2.50 (1.25-5.00) Seventh-Day Adventist men (Lindsted et al., 1991b) 9,484 low vs moderately activity 1.82 (1.28-2.63)
Danish men (Hein et al., 1992) 4,999 low vs high leisure-time activity 1.70 (1.20-2.30)
British men (Shaper et al., 1994) 5,694 inactive vs moderate/vigorously active 2.00 (1.11-5.00)
Asian-American men 7,074 low vs high tertile 1.18 (0.88-1.54) ARIC Study women (Folsom et al., 1997) 84,129 <1.0 hr/wk vs >5.5 hr/wk 1.41 (1.15-1.75)
British men (Wannamethee et al., 2000) 5,159 inactive vs moderately active 2.17 (1.56-3.03)
Irish and French men (Wagner et al., 2002) 9,758 low vs high tertile 1.52 (1.04-2.17) Stroke Finnish women (Salonen et al., 1982) 3,688 none vs some leisure 1.30 (0.73-2.16)* Finnish men (Salonen et al., 1982) 3,978 none vs some leisure 1.00 (0.65-1.62)* Swedish men (Harmsen et al., 1990) 7,495 physical activity score 1 vs scores 2-4
1.20 (0.80-1.80) Seventh-Day Adventist men (Lindsted et al., 1991b) 9,484 low vs moderate activity 1.28 (1.00-1.64)
British men (Wannamethee and Shaper, 1992) 7,630 none vs moderate 1.67 (0.67-5.00)
Asian-American men 7,530 low vs high tertile 3.70 (1.30-10.4)
Framingham Study men (Kiely et al., 1994) 1,361 tertile 1 vs tertile 3 2.27 (1.47-3.45)
Framingham Study women (Kiely et al., 1994) 1,862 tertile 1 vs tertile 3
1.08 (0.69-1.69) NHANEFS white women (Gillum et al., 1996) 1,473 low vs high activity 3. 13 (0.95-10.32) NHANEFS white men (Gillum et al., 1996) 1,285 low vs high activity 1.24 (0.63-2.41)
Swedish men (Rosengren and Wilhelmsen, 1997) 7,142 sedentary vs moderate/high activity 1.12 (0.61-2.04) Dutch men (Bijnen et al., 1998) 802 low vs middle tertile 1.54 (0.80-3.03) Harvard University alumni 11,130 <4,184 kJ/wk vs 8,368-12,548 kJ/wk 1.85 (1.32-2.63)
Reykjavik men (Agnarsson et al., 1999) 4,484 none vs some after age 40
1.45 (0.99-2.13)
ARIC Study men and women (Evenson et al., 1999) 14,575 low vs high quartile 1.12 (0.73-1.75) U.S. male physicians (Lee et al., 1999) 21,823 none vs vigorous 2-4 times/wk 1.25 (1.01-1.54) U.S. female nurses 72,488 low vs high quintile 1.52 (1.10-2.13) (continued)
Hypertension
Harvard University alumni (Paffenbarger et al., 1983) 14,998 <8,372 kJ/wk vs ≥8,372 kJ/wk 1.30 (1.09-1.55)
Iowa women (Folsom et al., 1990) ARIC Study white women (Pereira et al., 1999) 3,339 low vs high quartile 0.92 (0.67-1.25) ARIC Study white men (Pereira et al., 1999) 2,912 low vs high quartile 1.52 (1.06-2.13)
Colon Cancer Swedish men (Gerhardsson et al., 1986) 1,100,000 sedentary vs active occupation 1.30 (1.18-1.54)* Swedish men and women (Gerhardsson et al., 1988) 16,477 light vs hard exercise in leisure time 1.60 (1.00-2.70)
Danish women (Lynge and Thygesen, 1988) (Giovannucci et al., 1995) 47,723 low vs high quintile 1.89 (1.14-3.13) U.S. female nurses (Giovannucci et al., 1996) 13,057 low vs high quintile 1.72 (1.16-2.50)
Norwegian women (Thune and Lund, 1996) 28,274 sedentary vs active 1.59 (0.96-2.56)
Norwegian men (Thune and Lund, 1996) Breast Cancer U.S. college alumni (Frisch et al., 1987) 5,398 college nonathletes vs athletes 1.86 (1.00-3.47)
NHANEFS women (Albanes et al., 1989) 7,407 little/no exercise vs much exercise 1.00 (0.60-1.60)
Framingham Heart Study women (Dorgan et al., 1994) (Wyshak and Frisch, 2000) 3,940 college nonathletes vs athletes 1.65 (1.20-2.28)
Finnish women (Luoto et al., 2000) 30,548 <once/wk vs daily leisure-time activity 0.99 (0.70-1.39) U.S. women (Lee et al., 2001) 39,322 <840 kJ/wk vs ≥6,300 kJ/wk 1.49 (1.00-2.27) NHANEFS women (Breslow et al., 2001) 6,160 consistently high vs low activity 1.72 (0.93-3.23)
Danish women (Dirx et al., 2001) 2,924 < 30 min/day vs >90 min/day leisure 1.32 (1.01-1.72)
Swedish twins (Moradi et al., 2002) 9,539 sedentary vs regular leisure-time activity 1.67 (1.00-2.50)
Type 2 Diabetes U.S. female nurses (Manson et al., 1991) 87,253 none vs vigorous exercise once/wk 1.45 (1.00-2.08) U.S. male physicians 21,271 none vs vigorous exercise once/wk 1.41 (1.10-1.79) U.S. men and women (Lipton et al., 1993) 11,097 inactive vs very active 1.28 (1.06-1.56)
Asian-American men (Burchfiel et al., 1995) 6,815 lower four vs upper quintile 1.72 (1.28-2.38)
British men (Perry et al., 1995) 7,097 inactive vs moderately active 2.50 (1.43-5.00)
Finnish men (Lynch et al., 1996) 897 less vs ≥5.5 METs at least 40 min/wk 2.27 (1.14-4.55) Finnish women (Haapanen et al., 1997) (Hu et al., 1999) 27,546 low vs high quintile 1.35 (1.12-1.61) British men (Wannamethee et al., 2000) 5,159 inactive vs moderately active 2.08 (1.27-3.57)
Male physicians (Hu et al., 2001) 37,918 low vs high quintile 1.61 (1.32-2.00) Osteoporosis U.S. women (Sorock et al., 1988) 1,926 none vs regular physical activity 1.35 (0.85-2.17) U.S. men (Sorock et al., 1988) 1,158 none vs regular physical activity 2.04 (0.81-5.26) NHANEFS white women (Farmer et al., 1989) 2,143 none vs much or moderate exercise 1.90 (1.04-3.30)
British men and women (Wickham et al., 1989) Norwegian women (Meyer et al., 1993) 23,939 sedentary vs nonsedentary leisure 1.45 (0.99-2.08)
Norwegian men (Meyer et al., 1993) 24,484 sedentary vs nonsedentary leisure 0.78 (0.38-1.61) U.S. white women (Cummings et al., 1995) 9,516 not walking vs walking for exercise 1.43 (1.11-2.00) Non-black U.S. women (Gregg et al., 1998) 9,704 <1,423 kJ/wk vs >9,209 kJ/wk 1.56 (1.12-2.22)
Norwegian women (Joakimsen et al., 1998) 3,288 low vs high leisure-time activity 1.67 (0.71-3.33) Norwegian men (Joakimsen et al., 1998) 3,901 low vs high leisure-time activity 2.50 (1.11-5.00) Finnish men 3,262 none vs some vigorous physical activity (Jousilahti et al., 1996) U.S. male health professionals (Walker et al., 1996) 28,643 BMI ≥27.7 vs ≤23.0 kg/m 2 1.29 (0.73-2.27) U.S. female nurses (Rexrode et al., 1997) 116,759 BMI ≥32 vs <21 kg/m 2 1.59 (1.22-2.08) British men (Shaper et al., 1997) Colon Cancer Seventh-Day Adventist women (Phillips and Snowdon, 1985) 8,299 ≥125 vs 100-109% desirable MRW 1.00 (0.60-2.00) Seventh-Day Adventist men (Phillips and Snowdon, 1985) 14,216 ≥125 vs 100-109% desirable MRW 3.30 (1. 30-8.40) Male Harvard alumni (Lee and Paffenbarger, 1992) 17,595 BMI ≥26 vs <22.5 kg/m 2 1.52 (1.06-2.17) Iowa women (Bostick et al., 1994) 35,216 BMI >30.62 vs <22.90 kg/m 2 1.41 (0.90-2.23) U.S. male health professionals (Giovannucci et al., 1995) 31,055 BMI ≥29 vs <22 kg/m 2 1.48 (0.89-2.46) U.S. female nurses (Giovannucci et al., 1996) 13,057 BMI ≥29 vs <21 kg/m 2 1.50 (1.02-2.21) U.S. female nurses (Martinez et al., 1997) Hawaiian women (Galanis et al., 1998) 17,628 BMI >26.0 vs <19.6 kg/m 2 1.50 (1.00-2.30) U.S. women (Petrelli et al., 2002) Framingham Heart Study men (Felson et al., 1988) 589 quintile 5 vs quintiles 1-3 MRW 1.54 (1.18-2.02) U.S. women (Carman et al., 1994) 371 20% > ideal weight vs ideal weight 1.59 (1.10-2.31) U.S. men (Carman et al., 1994) *RR and 95% CI read from a figure. **Sample size provided for combined sample of men and women only.
Seven chronic diseases have consistently been shown to be associated with physical inactivity, including coronary artery disease, stroke, hypertension, colon cancer, breast cancer, type 2 diabetes, and osteoporosis. Further, there are sufficient long-term prospective studies to identify eight diseases associated with obesity: coronary artery disease, stroke, hypertension, colon cancer, postmenopausal breast cancer, type 2 diabetes, gall bladder disease, and osteoarthritis. Summary relative risk (RR) estimates were calculated using a general variance-based method of meta-analysis (Petitti, 1994) . In order to be considered for inclusion in these analyses, the study had to have reported a point estimate of RR as well as a 95% confidence interval (CI) for the point estimate. In a few cases, 95% CIs were calculated from the 90% CIs reported by the authors.
The impacts of physical inactivity and obesity on society were then estimated by calculating the population attributable risks (PAR%) for each disease, which combines the summary RR estimate with the population prevalence (P) of physical inactivity or obesity as follows:
For the purpose of calculating the PAR%, the prevalences of physical inactivity and obesity were obtained from the 2000/2001 Canadian Community Health Survey. The prevalence of obesity (body mass index [BMI] ≥ 30 kg/m 2 ) among Canadian adults 20-64 years of age was 14.7%, while the prevalence of physical inactivity (expending <6.3 kJ·kg -1 ·day -1 ) among Canadians 12 years and older was 53.5% (Statistics Canada, 2002) . For the average person, this level of physical activity equates to walking approximately 1 mile (1.6 km) per day. The different age ranges for the prevalences of physical inactivity vs. obesity are simply the result of differences in reporting across these variables by Statistics Canada.
The direct and indirect costs of the diseases related to (not attributed to) physical inactivity and obesity were primarily estimated from information on the costs of specific diseases in the Economic Burden of Illness in Canada [EBIC], 1998 (Health Canada, 2002 and in the EBIC 1993 (Moore et al., 1997) . Direct costs are defined as the values of goods and services for which payment was made and resources were used in treatment, care, and rehabilitation related to illness or injury. The five direct cost components of the EBIC 1998 include hospital care expenditures, drug expenditures, physician care expenditures, costs for care in other institutions, and additional direct health expenditures (other professionals, public health, health research, prepayment administration, etc.). Indirect costs are defined as the value of economic output lost because of illness, injury-related work disability, or premature death. The indirect cost components in the EBIC 1998 were measured in terms of the value of years of life lost due to premature death and the value of activity days lost due to short-term and long-term disability. Using this strategy, the total health expenditures in Canada in 1998 are estimated to have been $159.4 billion, of which $84.0 billion were direct costs and $75.5 billion were indirect expenditures.
The specific costs associated with some diseases were not directly reported in the EBIC 1998 and were therefore estimated using the following approaches.
• The EBIC 1998 reported the total direct and indirect costs of treating cardiovascular disease, but did not have specific costs for coronary artery disease, stroke, and hypertension. The costs of coronary artery disease and stroke for 1998 were estimated by multiplying the proportional costs associated with treating coronary artery disease (28.2% direct, 42.8% indirect) and stroke (19.6% direct, 9.9% indirect) relative to total cardiovascular disease costs that were reported in the EBIC 1993. The cost of treating hypertension in 1998 was estimated by multiplying the proportion of direct (17.8%) and indirect (9.2%) cardiovascular disease costs attributable to hypertension in the U.S. (American Heart Association, 2002).
• The EBIC 1998 provided direct and indirect costs for all cancers combined, and we estimated the costs of treating colon and breast cancers using the actual incidence of colon (9.0%) and breast (14.4%) cancers relative to all newly diagnosed cancers in Canada in 1998 (National Cancer Institute of Canada, 2002). The costs of treating postmenopausal breast cancer was calculated using the estimated incidence of breast cancer in women age 50 and over relative to all Canadian women in 2002 (78.0%; National Cancer Institute of Canada, 2002).
• The EBIC 1998 reported the direct and indirect costs of treating endocrine and related diseases, but did not have a specific cost for diabetes. The cost of type 2 diabetes in 1998 was estimated by multiplying the proportion of the direct (43.3%) and indirect (26.8%) endocrine disease costs that were attributable to diabetes in the EBIC 1993 and by the proportion of diabetes cases that are type 2 diabetes (92.5%; U.S. Centers for Disease Control and Prevention [CDC], 1997).
• The EBIC 1998 reported the direct and indirect costs of treating digestive diseases, but did not have a specific cost for gall bladder disease. The proportion of digestive disease costs that was attributable to gall bladder disease in 1998 (15.5%) was calculated by multiplying the cost associated with gall bladder disease in the United States in 1986 (Colditz, 1992) relative to the cost of treating all digestive diseases in the U.S. in 1980 (Hodgson and Kopstein, 1984) , after the 1980 value was converted to a 1986 value using the medical component of the U.S. Consumer Price Index (U.S. Dept. of Labor, 2003) .
• The EBIC 1998 reported the direct and indirect costs of treating musculoskeletal diseases, but did not have a cost specifically for osteoarthritis or osteoporosis. We estimated the cost of osteoarthritis in 1998 by multiplying the cost for all musculoskeletal diseases relative to the proportion of musculoskeletal diseases that are arthritis (68.2%; Badley et al., 1994) and the proportion of arthritis cases that are osteoarthritis (49.2%; Lawrence et al., 1998) . The proportion of the direct and indirect costs of treating musculoskeletal diseases in the EBIC 1998 that were attributable to osteoporosis were determined by dividing the previously calculated direct cost for osteoporosis in Canada in 1993 ($744.4 million; Goeree et al., 1996) by the total direct cost of musculoskeletal diseases in the EBIC 1993 (30.3%).
The final step in estimating the health care costs of physical inactivity and obesity was to apply the PAR% values calculated from the RR of disease and population prevalences of physical inactivity and obesity to the health costs derived from the EBIC 1998 as described above. In this way, the health care costs directly attributable to physical inactivity and obesity were determined.
The health care costs calculated for the diseases of interest in the EBIC 1998 were inflated to 2001 dollars by using the percentage increase in total health care costs between 1998 and 2001 in Canada (26.3% increase) reported in the Cana- To determine the influence of variations in PAR% and health care costs, a two-way sensitivity analysis similar to that of previous studies on the costs of physical inactivity and obesity in Canada was conducted (Birmingham et al., 1999; Katzmarzyk et al., 2000) . Each PAR% and disease-specific health care cost was simultaneously varied by ± 20% of the mean estimate.
Results
The summary RR estimates for each disease associated with physical inactivity and obesity are presented in Table 3 . The increased risk of disease due to physical inactivity ranges from 1.30 for hypertension to 1.60 for stroke, while the increased risk of disease associated with obesity ranges from 1.45 for colon cancer to 4.50 for hypertension.
The PAR% is a statistic that couples the RR of a disease due to a given risk factor with the prevalence of the risk factor in the population; it reflects the burden of that disease in society which is directly attributable to that risk factor. The PAR% for each disease is shown in Table 3 . The PAR% values indicate that 13.8% (hypertension) to 24.3% (stroke) of the chronic diseases associated with physical inactivity in Canada are directly attributable to physical inactivity. Likewise, 6.2% (colon cancer) to 34.0% (hypertension) of the chronic diseases associated with obesity in Canada are directly attributable to obesity. The economic burden of physical inactivity (Table 4 ) was $5.3 billion in the year 2001. Of this, $1.6 billion was spent on direct costs and $3.7 billion on indirect costs. The health care costs of physical inactivity represented 2.6% of the total health care costs ($201.3 billion): 1.5% of the total direct costs ($106.0 billion) and 3.9% of the total indirect costs ($95.3 billion) in Canada in 2001. The sensitivity analysis indicated that the health care costs for the major chronic diseases attributable to inactivity may have been as low as $3.4 billion ($1.0 billion in direct costs and $2.4 billion in indirect costs) and as high as $7.6 billion ($2.3 billion in direct costs and $5.3 billion in indirect costs). The three most expensive diseases associated with physical inactivity were coronary artery disease ($1.7 billion), osteoporosis ($1.5 billion), and stroke ($765 million) ( Table 4) .
The economic burden of obesity (Table 5 ) was $4.3 billion in the year 2001. Of this, $1.6 billion was spent on direct costs and $2.7 billion on indirect costs. The health care costs of obesity represented 2.2% of the total health care costs ($201.3 billion), 1.5% of the total direct costs ($106.0 billion), and 2.9% of the total indirect costs ($95.3 billion) in Canada in 2001. The sensitivity analysis indicated that the health care costs for the major chronic diseases attributable to obesity may have been as low as $2.8 billion ($1.0 billion in direct costs and $1.8 billion in indirect costs) and as high as $6.3 billion ($2.3 billion in direct costs and $4.0 billion in indirect costs). The three most expensive diseases associated with treating obesity were coronary artery disease ($1.3 billion), hypertension ($979 million), and osteoarthritis ($881 million) (Table 5) . 
Discussion
The results of this analytical review indicate that $5.3 billion, or about 2.6% of total health care costs in Canada in 2001, were directly attributable to physical inactivity. In the same year $4.3 billion, or about 2.2% of total health care costs, were directly attributable to obesity. These results confirm that physical inactivity and obesity are major contributors to the public health burden in Canada, and provide convincing evidence that reducing physical inactivity and obesity would substantially reduce health care spending. Given that most of the studies relating physical activity levels to disease risk used in this report (Table 1) included the BMI or another index of obesity as a covariate in the analyses, the effects of physical activity on disease risk and health care costs can be considered to be independent of the effects of obesity. On the other hand, most of the studies of obesity and disease risk (Table 2) did not include an index of physical activity as a covariate, so the results are partially influenced by the effects of physical activity. Since individuals become obese by disrupting energy balance in a way in which energy expenditure (physical activity, resting metabolic rate, thermic effect of feeding) falls below the level of energy intake (dietary kilocalories), physical activity levels undoubtedly play a role in the development of obesity in a substantial number of people. However, there is no consensus as to whether the current obesity epidemic in North America is primarily the result of high levels of physical inactivity or high dietary intake of energy-dense foods, and it is likely that both dietary intake and physical inactivity have played a role in the increasing prevalence of overweight and obesity.
The interplay between physical activity levels and obesity can be observed using cross-sectional data from the 2000/2001 Canadian Community Health Sur- vey (Statistics Canada, 2002) . The prevalence of sedentariness in leisure time (expending <6.3 kJ·kg -1 ·day -1 ) was 66% in obese participants (BMI ≥ 30 kg/m 2 ) compared with 57% in non-obese participants. Comparing the two groups using a crude risk ratio, the risk of being sedentary in leisure time was 16% higher in the obese group. In a study by King and colleagues (King et al., 2001 ) using data from a representative sample of American adults, the likelihood of obesity among individuals who were physically active in leisure time (≥5 bouts of activity/week) was approximately 50% lower than among those who were physically inactive, regardless of occupational physical activity level. Although cause-and-effect conclusions cannot be drawn from the results of these cross-sectional analyses, there is indeed a relationship between physical activity levels and obesity, wherein physically inactive persons are more likely to be obese compared to active people. Studies that have tried to prospectively predict the development of obesity or changes in body weight from physical activity levels have yielded mixed results (Fortier et al., 2002; Williamson, 1996) . More research is required before a primary etiologic role can be delineated for physical inactivity in the development of obesity.
It has been suggested that the economic costs of obesity and physical inactivity can be summed to indicate the true cost of physical inactivity (Colditz, 1999) . However, to do so one must assume that physical inactivity is the sole cause of obesity, which it likely is not, as discussed above. Thus the true total economic impact of physical inactivity would ideally include the total independent costs attributed to physical inactivity as well as the physical inactivity-related portion of the costs specifically attributed to obesity. More research is needed to untangle the independent effects of these two related risk factors on the public health of Canadians.
It is important to note that the costs attributed to obesity reported here are based on the prevalence of individuals with a BMI ≥30.0 kg/m 2 , as this is the currently accepted definition of obesity (U.S. NIH, 1998; World Health Organization [WHO], 1998). However, health risks increase across normal-weight (BMI 18.5-24.9 kg/m 2 ) to overweight (BMI 25.0-29.9 kg/m 2 ) to obese (BMI ≥30.0 kg/ m 2 ) categories (U.S. NIH, 1998; WHO, 1998) . Given that 33% of Canadians are classified as overweight and 14.7% are obese by these criteria (Statistics Canada, 2002) , by focusing only on obesity the current report underestimates the economic impact of excess body weight in Canada.
Two previous reports have provided national estimates of the economic impact of obesity (Birmingham et al., 1999) and physical inactivity (Katzmarzyk et al., 2000) for Canada. For a number of reasons, the results given in the present report are not directly comparable to the ones in these previous estimates. Both of these reports gave only the direct health care costs while the present report included both direct and indirect economic costs. In 1997, obesity was estimated to account for 2.4% of direct health care expenditures in Canada (Birmingham et al., 1999) , whereas the costs of obesity for Canada in 2001 presented here accounted for 1.5% of direct health care expenditures. In the prior report on the economic cost of obesity in Canada (Birmingham et al., 1999) , obesity was defined as having a BMI ≥27 kg/m 2 , and thus the prevalences of obesity using this definition are higher than those reported here (BMI ≥30 kg/m 2 ), which influenced the PAR% values upward.
Another difference between the two studies is that Birmingham et al. (1999) chose not to include the effects of obesity on osteoarthritis, which was one of the leading obesity-related costs in the present analysis. However, Birmingham et al. did include the effects of obesity on endometrial cancer, hyperlipidemia, pulmonary embolism, and rectal cancer, which together accounted for 6.2% of the costs of obesity. Although we agree that obesity may have an impact on the additional illnesses included in the analysis of Birmingham et al. (1999) , a lack of prospective studies documenting a relationship with obesity caused us to choose a more conservative approach for the current analysis.
The report on the economic cost of physical inactivity in Canada in 1999 (Katzmarzyk et al., 2000) also yielded different results than the present analysis. Physical inactivity accounted for 2.5% of direct health care expenditures in Canada in 1999, whereas in 2001 they only accounted for 1.5% of the direct health care expenditures. A different definition of physical inactivity was used in this report (<6.3 kJ·kg -1 ·day -1 ) compared to the prior Canadian report (<12.6 kJ·kg -1 ·day -1 ), which used the physical inactivity prevalence (62%) from the Canadian Fitness and Lifestyle Research Institute's Physical Activity Monitor Survey (Craig et al., 1999) for 1997.
For the present study we chose the estimate from the 2000/2001 Canadian Community Health Survey (53.5%; Statistics Canada, 2002) , given that it is a much larger survey and may produce more robust estimates. Furthermore, in the 1999 analysis the PAR% for coronary heart disease was 35.8%, using a relative risk of 1.9 obtained from a published meta-analysis (Berlin and Colditz, 1990 ). In the current analysis we used a relative risk of 1.45, based on the present metaanalysis that included many recent studies published subsequent to the Berlin and Colditz meta-analysis (1990) . This reduced the PAR% for coronary artery disease to 19.4%. Given these differences, the estimate of the relative economic impact of physical inactivity in Canada in 2001 was lower than the estimate for 1999. However, as described above, these results are not directly comparable. Kaiserman (1997) estimated that smoking accounted for 3.8% of the total health care costs in Canada in 1991. The health costs for physical inactivity (2.6%) and obesity (2.2%) for Canada in 2001 are similar in proportion to those reported for smoking a decade earlier. The values for physical inactivity and obesity are particularly impressive, given that these health-care cost calculations only considered the percentage of the Canadian population who were inactive and obese in 2001. Thus, formerly inactive and obese persons were not considered. By comparison, the costs for smoking included both current smokers and former smokers, and since in that analysis former smokers represented 46% of those who ever smoked, the health care costs for current smokers alone would have been considerably lower. Nonetheless, about half of the health care costs attributable to smoking in 1991 were paid back to the government in the form of taxes imposed on tobacco sales (Kaiserman, 1997) . By comparison, it is not feasible or realistic to implement a tax directly on obese and sedentary individuals to help pay for their increased health care costs. An argument could also be made that obese and physically inactive people die earlier, and that because normal-weight and active individuals live longer, they ultimately use the health care system at the same rate. However, in addition to living longer, physically active persons maintain a higher quality of life-a reflection of their disease-free status and health care use-in their final years and months (Spirduso and Cronin, 2001 ).
This analytical review of the health care costs of physical inactivity and obesity used a prevalence-based cost-of-illness methodology. The use of a metaanalysis approach to summarize the available prospective studies rather than relying on relative risk estimates from a single study is a marked strength of the analysis. However, using the prevalence-based approach results in cost estimates that are more theoretical than they are concrete. Future studies should focus on employing incidence-based and cost-effectiveness methodologies to better inform public health policy.
In summary, the results presented in this review highlight the importance of promoting a physically active lifestyle and maintaining a healthy body weight. Physical inactivity and obesity have now reached epidemic proportions in Canada and account for a significant portion of health care spending. Future studies should address cost-benefit issues related to specific physical activity interventions so as to better plan public health approaches and policies that address these problems.
